Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency
- PMID: 18957504
- PMCID: PMC2630875
- DOI: 10.1210/jc.2008-1174
Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency
Abstract
Context: 21-Hydroxylase deficiency (21OHD) is caused by CYP21A2 gene mutations disrupting the adrenal 21-hydroxylase, P450c21. CYP21A2 mutations generally correlate well with the 21OHD phenotype, but some children with severe CYP21A2 mutations have residual 21-hydroxylase activity. Some hepatic P450 enzymes can 21-hydroxylate progesterone, but their physiological relevance in modifying 21OHD is not known.
Objective: We determined the ability of CYP2C19 and CYP3A4 to 21-hydroxylate progesterone and 17-hydroxyprogesterone (17OHP), determined the impact of the common P450 oxidoreductase (POR) variant A503V on these activities, and examined correlations between CYP2C19 variants and phenotype in patients with 21OHD.
Methods: Bacterially expressed, N-terminally modified, C-His-tagged human P450c21, CYP2C19, and CYP3A4 were combined with bacterially expressed wild-type and A503V POR. The 21-hydroxylation of radiolabeled progesterone and 17OHP was assessed, and the Michaelis constant (Km) and maximum velocity (Vmax) of the reactions were measured. CYP2C19 was genotyped in 21OHD patients with genotypes predicting severe congenital adrenal hyperplasia.
Results: Compared to P450c21, the Vmax/Km for 21-hydroxylation of progesterone by CYP2C19 and CYP3A4 were 17 and 10%, respectively. With both forms of POR, the Km for P450c21 was approximately 2.6 microm, the Km for CYP2C19 was approximately 11 microm, and the Km for CYP3A4 was approximately 110 microm. Neither CYP2C19 nor CYP3A4 could 21-hydroxylate 17OHP. The CYP2C19 ultrametabolizer allele CYP2C19 17 was homozygous in one of five patients with a 21OHD phenotype that was milder than predicted by the CYP21A2 genotype.
Conclusions: CYP2C19 and CYP3A4 can 21-hydroxylate progesterone but not 17OHP, possibly ameliorating mineralocorticoid deficiency, but not glucocorticoid deficiency. Multiple enzymes probably contribute to extraadrenal 21-hydroxylation.
Figures


Similar articles
-
The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.J Clin Endocrinol Metab. 2008 Jul;93(7):2913-6. doi: 10.1210/jc.2008-0304. Epub 2008 Apr 8. J Clin Endocrinol Metab. 2008. PMID: 18397975 Free PMC article.
-
Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.Acta Chim Slov. 2016;63(1):33-7. doi: 10.17344/acsi.2015.1797. Acta Chim Slov. 2016. PMID: 26970786
-
Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.Arch Biochem Biophys. 1997 Oct 1;346(1):161-9. doi: 10.1006/abbi.1997.0302. Arch Biochem Biophys. 1997. PMID: 9328296
-
Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.Horm Res Paediatr. 2019;91(6):416-420. doi: 10.1159/000501396. Epub 2019 Aug 26. Horm Res Paediatr. 2019. PMID: 31450227 Review.
-
P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.Sci Signal. 2012 Oct 23;5(247):pt11. doi: 10.1126/scisignal.2003318. Sci Signal. 2012. PMID: 23092891 Review.
Cited by
-
Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications.J Endocr Soc. 2025 Jan 28;9(3):bvaf018. doi: 10.1210/jendso/bvaf018. eCollection 2025 Feb 4. J Endocr Soc. 2025. PMID: 39911519 Free PMC article. Review.
-
Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency.Clin Chem. 2012 Feb;58(2):421-30. doi: 10.1373/clinchem.2011.174037. Epub 2011 Dec 7. Clin Chem. 2012. PMID: 22156666 Free PMC article.
-
Genotype Is Associated to the Degree of Virilization in Patients With Classic Congenital Adrenal Hyperplasia.Front Endocrinol (Lausanne). 2018 Dec 3;9:733. doi: 10.3389/fendo.2018.00733. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30559721 Free PMC article.
-
Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5.Toxicol Res. 2024 Jan 2;40(2):215-222. doi: 10.1007/s43188-023-00219-8. eCollection 2024 Apr. Toxicol Res. 2024. PMID: 38525137 Free PMC article.
-
Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.Mol Diagn Ther. 2017 Dec;21(6):663-675. doi: 10.1007/s40291-017-0296-6. Mol Diagn Ther. 2017. PMID: 28819757
References
-
- Therrell Jr BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S 1998 Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583–590 - PubMed
-
- Miller WL, Morel Y 1989 Molecular genetics of 21-hydroxylase deficiency. Ann Rev Genet 23:371–393 - PubMed
-
- White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291 - PubMed
-
- Dolzan V, Solyom J, Fekete G, Kovacs J, Rakosnikova V, Votava F, Lebl J, Pribilincova Z, Baumgartner-Parzer SM, Riedl S, Waldhauser F, Frisch H, Stopar-Obreza M, Krzisnik C, Battelino T 2005 Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 153:99–106 - PubMed
-
- Bachega TA, Billerbeck AE, Madureira G, Marcondes JA, Longui CA, Leite MV, Arnhold IJ, Mendonça BB 1998 Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 83:4416–4419 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources